MAPT and Alzheimer disease: For instance, oral treatment with nicotinamide improves cognitive performance and reduces Aβ and hyperphosphorylated tau pathologies in 3xTg-AD mice [34], and nicotinamide preserves cellular NAD+ levels and increases the resistance of neurons against excitotoxicity [35].